Kathleen Sebelius, Director at Humacyte, Inc. (HUMA), bought 56,818 shares at $0.88 ($50K) on 2026-05-19, disclosed to the SEC on 2026-05-20.
Open-market purchase of $50k HUMA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| MYOV | BUY | 2019-06-14 | $45K | — | Filing → |